Prostate Cancer - Results from #140

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. February 21, 2025

Photodynamic therapy for the precise treatment of localized prostate cancer. February 21, 2025

Specificity of a polygenic score for aggressive prostate cancer. February 21, 2025

Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study. February 20, 2025

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer. February 20, 2025

On-treatment PSA kinetics as a potential biomarker: Guiding personalized treatment in metastatic hormone-sensitive prostate cancer. February 20, 2025

Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy. February 20, 2025

CRISPR screening identifies regulators of enhancer-mediated androgen receptor transcription in advanced prostate cancer. February 20, 2025

Clarity Receives US FDA Fast Track Designation for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients with Cu-67 SAR-bisPSMA February 19, 2025

Clinical and Translational Results from PORTER, a Multi-cohort Phase 1 Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer. February 19, 2025

Is Extraordinary Response and Long-Term Remission of Metastatic Castration-Resistant Prostate Cancer (mCRPC) After [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy Due to an Immunomodulatory Effect (Radiovaccination)? A Dual Center Experience on Super-Responders. February 19, 2025

Social risk factors screening preferences among breast and prostate cancer survivors: A qualitative study. February 19, 2025

Impact of Prostate Cancer Treatment on Quality of Life of LGBTQ+ Patients: A Systematic Review. February 19, 2025

Validation of the Barcelona Magnetic Resonance Imaging Predictive Model for Significant Prostate Cancer Detection in Men Undergoing Mapping per 0.5 Mm-Core Targeted Biopsies of Suspicious Lesions and Perilesional Areas. February 19, 2025

Effects on Quality of Life and Self-Efficacy of Instant Messaging Services in Self-Management Programs for Prostate Cancer: A Systematic Review and Meta-Analysis. February 19, 2025

Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial. February 18, 2025

Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients. February 18, 2025

The lived experience of active surveillance for prostate cancer: a systematic review and meta-synthesis. February 18, 2025

Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer. February 18, 2025

Mainstreaming improved adoption of germline testing for Veterans Affairs patients with metastatic prostate cancer without exacerbating disparities. February 18, 2025

Page 8 of 1467